751611118	751611118	CD	B-NP	O
|	|	NN	I-NP	O
AH	AH	NN	I-NP	O
|	|	NN	I-NP	O
51425337	51425337	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6073380	6073380	CD	B-NP	O
|	|	CC	I-NP	O
7/14/2007	7/14/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Stable	Stable	NNP	I-NP	O
Angina	Angina	NNP	I-NP	O
,	,	,	O	O
Atrial	Atrial	NNP	B-NP	O
Flutter	Flutter	NNP	I-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/17/2007	3/17/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/11/2007	6/11/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
BELLE	BELLE	NNP	B-NP	O
,	,	,	O	O
WAYLON	WAYLON	NNP	B-NP	O
416-43-23-8	416-43-23-8	CD	I-NP	O
Dale	Dale	NNP	I-NP	O
West	West	NNP	I-NP	O
Norfcean	Norfcean	NNP	I-NP	O
Villesanch	Villesanch	NNP	I-NP	O
Couen	Couen	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/27/07	10/27/07	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SUND	SUND	NN	B-NP	O
,	,	,	O	O
KENETH	KENETH	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
100	100	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ECASA	ECASA	NN	B-NP	B-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/14/07	9/14/07	CD	B-NP	O
by	by	IN	B-PP	O
BLONIGAN	BLONIGAN	NNP	B-NP	O
,	,	,	O	O
SAUL	SAUL	NNP	B-NP	O
VINCE	VINCE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
553589051	553589051	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/14/07	9/14/07	CD	B-NP	O
by	by	IN	B-PP	O
MACLELLAN	MACLELLAN	NNP	B-NP	O
,	,	,	O	O
VANCE	VANCE	NNP	B-NP	O
WINFORD	WINFORD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
153922043	153922043	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
war	war	NN	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/14/07	9/14/07	CD	B-NP	O
by	by	IN	B-PP	O
PONDS	PONDS	NN	B-NP	B-protein
,	,	,	O	O
MOHAMED	MOHAMED	NNP	B-NP	O
GRANT	GRANT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PLAVIX	PLAVIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
766998149	766998149	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TICLOPIDINE	TICLOPIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DOXAZOSIN	DOXAZOSIN	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/14/07	9/14/07	CD	B-NP	O
by	by	IN	B-PP	O
CHICON	CHICON	NNP	B-NP	O
,	,	,	O	O
XAVIER	XAVIER	NNP	B-NP	O
COLTON	COLTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
war	war	NN	B-NP	O
HYDRALAZINE	HYDRALAZINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

IMDUR	IMDUR	NN	B-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
METHADONE	METHADONE	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q12H	Q12H	NN	I-NP	I-protein
LOPRESSOR	LOPRESSOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
METOPROLOL	METOPROLOL	NN	I-NP	I-protein
TARTRATE	TARTRATE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
12.5	12.5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
90	90	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
PRN	PRN	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
for	for	IN	B-PP	O
ECHO	ECHO	NN	B-NP	B-protein
and	and	CC	B-PP	O
for	for	IN	B-PP	O
Heart	Heart	NNP	B-NP	O
Monitoring	Monitoring	NNP	I-NP	O
,	,	,	O	O
Please	Please	NNP	B-NP	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Kappe	Kappe	NNP	I-NP	O
at	at	IN	B-PP	O
405-871-1704	405-871-1704	CD	B-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
follow-up	follow-up	JJ	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
TICLOPIDINE	TICLOPIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Stable	Stable	NNP	B-NP	O
Angina	Angina	NNP	I-NP	O
,	,	,	O	O
Atrial	Atrial	NNP	B-NP	O
Flutter	Flutter	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Stable	Stable	NNP	I-NP	O
Angina	Angina	NNP	I-NP	O
,	,	,	O	O
Atrial	Atrial	NNP	B-NP	O
Flutter	Flutter	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
CABG	CABG	NNP	I-NP	O
,	,	,	O	O
S/P	S/P	NNP	B-NP	O
PTCA	PTCA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
GOUT	GOUT	NN	B-NP	B-protein
,	,	,	O	O
PROTEINURIA	PROTEINURIA	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
hypertriglyceridemia	hypertriglyceridemia	NN	B-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
,	,	,	O	O
Hep	Hep	NNP	B-NP	B-protein
B	B	NNP	I-NP	I-protein
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
,	,	,	O	O
COPD	COPD	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
***	***	SYM	B-NP	O
hpi	hpi	NN	I-NP	O
:	:	:	O	O
60M	60M	NN	B-NP	O
w/known	w/known	JJ	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
88	88	CD	B-NP	O
'	'	SYM	B-ADJP	O
with	with	IN	B-PP	O
stenting	stente	VBG	B-VP	O
since	since	IN	B-PP	O
-LRB-	-LRB-	NN	B-NP	B-protein
last	last	RB	B-ADVP	O
in	in	IN	B-PP	O
9/21	9/21	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
w/3	w/3	NN	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
on	on	IN	B-PP	O
4/30/06	4/30/06	CD	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Responded	Respond	VBN	B-VP	O
to	to	TO	B-PP	O
NTG	NTG	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
recurred	recur	VBD	B-VP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
came	come	VBD	B-VP	O
in	in	IN	B-PP	O
-	-	HYPH	B-NP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
markers	marker	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Got	Got	NN	B-NP	O
Heparin	Heparin	NN	I-NP	O
bolus	bolus	NN	I-NP	O
only	only	RB	B-ADVP	O
,	,	,	O	O
NTG	NTG	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
,	,	,	O	O
morphine	morphine	NN	B-NP	O
,	,	,	O	O
maalox/nexium/zofran	maalox/nexium/zofran	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
new	new	JJ	B-NP	O
aflutter	aflutter	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/6/06	10/6/06	CD	B-NP	O
,	,	,	O	O
felt	feel	VBD	B-VP	O
much	much	RB	B-ADJP	O
better	good	JJR	I-ADJP	O
and	and	CC	O	O
back	back	RB	B-ADVP	O
in	in	IN	B-PP	O
NSR	NSR	NN	B-NP	B-protein
***	***	SYM	B-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
CABG	CABG	NN	I-NP	O
in	in	IN	B-PP	O
1988	1988	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
DMII	DMII	NN	B-NP	B-protein
,	,	,	O	O
Pancytopenia	Pancytopenia	NNP	B-NP	O
,	,	,	O	O
hep	hep	NN	B-NP	B-DNA
B	B	NNP	I-NP	I-DNA
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
***	***	NNP	I-NP	O
Home	Home	NNP	I-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
gemfibrizol	gemfibrizol	NN	B-NP	O
,	,	,	O	O
imdur	imdur	NN	B-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
,	,	,	O	O
doxazosin	doxazosin	NN	B-NP	O
,	,	,	O	O
sl	sl	NN	B-NP	O
NTG	NTG	NNP	I-NP	O
***	***	NNP	I-NP	O
ALL	ALL	NNP	I-NP	O
:	:	:	O	O
Ticlid	Ticlid	NNP	B-NP	O
,	,	,	O	O
NSAIDS	NSAIDS	NNP	B-NP	O
***	***	SYM	I-NP	O
Admit	Admit	NNP	I-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
96.5	96.5	CD	B-NP	O
P40	P40	NN	I-NP	B-protein
's	's	POS	B-NP	O
BP	BP	NN	I-NP	O
138/80	138/80	CD	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
,	,	,	O	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
S2	S2	NN	I-NP	I-protein
1/6	1/6	CD	I-NP	I-protein
SEW	SEW	NNP	I-NP	O
at	at	IN	B-PP	O
USB	USB	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
***	***	SYM	B-NP	O
Data	Data	NN	I-NP	O
:	:	:	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
w/slow	w/slow	NN	I-NP	O
v	v	NN	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
***	***	SYM	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
60M	60M	NN	B-NP	O
w/known	w/known	NN	I-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
new	new	JJ	B-NP	O
aflutter	aflutter	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
w/chest	w/ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
has	have	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

C	C	NN	B-NP	O
:	:	:	O	O
-LSB-	-LSB-	SYM	O	O
I	I	PRP	B-NP	O
-RSB-	-RSB-	NN	B-NP	O
:	:	:	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
likely	likely	RB	B-ADVP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
angina	angina	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
gtt	gtt	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
stopped	stop	VBD	B-VP	O
after	after	IN	B-PP	O
negative	negative	JJ	B-NP	O
markers	marker	NNS	I-NP	O
X	X	NN	I-NP	B-DNA
2	2	CD	I-NP	I-DNA
,	,	,	O	O
stayed	stay	VBN	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

Likely	Likely	RB	B-NP	O
long-term	long-term	JJ	I-NP	O
uncorrectable	uncorrectable	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
stable	stable	JJ	I-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

Continued	Continued	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Statin	Statin	NNP	B-NP	O
,	,	,	O	O
Gemfibrizol	Gemfibrizol	NNP	B-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
-LSB-	-LSB-	NNP	I-NP	O
P	P	NNP	I-NP	O
-RSB-	-RSB-	NNP	I-NP	O
:	:	:	O	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
last	last	JJ	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
get	get	VB	I-VP	O
ECHO	ECHO	NN	B-NP	B-protein
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
Hydral	Hydral	NNP	I-NP	O
,	,	,	O	O
Norvasc	Norvasc	NNP	B-NP	O
,	,	,	O	O
Doxazosin	Doxazosin	NNP	B-NP	O
-	-	HYPH	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Continued	Continued	NNP	B-NP	O
lasix	lasix	CD	I-NP	O
-LSB-	-LSB-	NNP	I-NP	O
R	R	NNP	I-NP	O
-RSB-	-RSB-	NNP	I-NP	O
:	:	:	O	O
Had	Have	VBD	B-VP	O
new	new	JJ	B-NP	O
aflutter	aflutter	NN	I-NP	O
on	on	IN	B-PP	O
floor	floor	NN	B-NP	O
and	and	CC	O	O
promptly	promptly	RB	B-VP	O
went	go	VBD	I-VP	O
back	back	RB	B-ADVP	O
into	into	IN	B-PP	O
afib	afib	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
start	start	VB	I-VP	O
antiarhythmic	antiarhythmic	JJ	B-ADJP	O
and	and	CC	O	O
no	no	DT	B-NP	O
long-term	long-term	JJ	I-NP	O
anticoag	anticoag	NN	I-NP	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
and	and	CC	I-NP	O
plavix	plavix	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
get	get	VB	I-VP	O
cardiac	cardiac	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	B-protein
ENDO	ENDO	NN	I-NP	I-protein
:	:	:	O	O
DMII	DMII	NN	B-NP	O
with	with	IN	B-PP	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
Gout	Gout	NN	B-NP	O
,	,	,	O	O
HBA1c	HBA1c	NN	B-NP	O
pending	pending	NN	I-NP	O
,	,	,	O	O
Will	Will	NNP	B-NP	O
continue	continue	VBP	B-VP	O
methadone	methadone	NN	B-NP	O
and	and	CC	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
*	*	SYM	B-NP	O
Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
CRI	CRI	NN	B-NP	O
,	,	,	O	O
Cr	Cr	NN	B-NP	O
w/in	w/in	NN	I-NP	O
baseline	baseline	NN	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
GERD	GERD	NNP	B-NP	O
-	-	HYPH	B-NP	O
Gave	Gave	NNP	I-NP	O
PPI	PPI	NNP	I-NP	O
*	*	NNP	I-NP	O
Code	Code	NNP	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

Rather	Rather	RB	B-ADVP	O
this	this	DT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-NP	O
angina	angina	NN	I-NP	O
and	and	CC	O	O
your	your	PRP$	B-NP	O
current	current	JJ	I-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
is	be	VBZ	B-VP	O
maximized	maximize	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
also	also	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
fast	fast	JJ	I-NP	O
heart	heart	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
called	call	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
when	when	WRB	B-ADVP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
,	,	,	O	O
but	but	CC	O	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
rhythm	rhythm	NN	I-NP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
.	.	.	O	O

Thus	Thus	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
medications	medication	NNS	I-NP	O
are	be	VBP	B-VP	O
being	be	VBG	I-VP	O
started	start	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
you	you	PRP	B-NP	O
will	will	MD	B-VP	O
get	get	VB	I-VP	O
an	an	DT	B-NP	O
ECHO	ECHO	NN	I-NP	B-protein
and	and	CC	O	O
also	also	RB	B-ADVP	O
some	some	DT	B-NP	O
heart	heart	NN	I-NP	O
monitoring	monitoring	NN	I-NP	O
that	that	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sapper	Sapper	NNP	I-NP	O
You	You	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
times	time	NNS	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
medications	medication	NNS	I-NP	O
that	that	IN	B-NP	O
you	you	PRP	B-NP	O
were	be	VBD	B-VP	O
previously	previously	RB	I-VP	O
taking	take	VBG	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
light-headedness	light-headedness	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	B-DNA
PCP	PCP	NN	I-NP	I-DNA
-	-	HYPH	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
ECHO	ECHO	NN	B-NP	B-protein
and	and	CC	O	O
Cardiac	Cardiac	JJ	B-NP	O
Monitoring	Monitoring	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
THURTON	THURTON	NNP	B-NP	O
,	,	,	O	O
EMMITT	EMMITT	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AC857	AC857	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/27/07	10/27/07	CD	I-NP	O
@	@	HYPH	B-NP	O
12	12	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

